selling on a bullish announcement, page-18

Guys, yes - we have a slight issue on our hands with regards to short term traders taking profits and bolting AND with the dilution of stock as a result of the SPP program. But think about what's to come:

1. Today's ann was big, very big indeed. But if you think it's had it's full effect, think again. The positive effect of today's news will permeate PRR's SP well into the short-medium term. Think about it - a major region in the world has TAKEN ABOARD CVAC. That means the darn thing WORKS. The major, major factor that keeps biotech companies down is uncertainty as to whether the product will work - that has LARGELY been cancelled today! Give it a couple of weeks for the majority of the community to let it sink in, and grab a bag of popcorn!

2. The N-bomb. Someone, I think it was adbm, very validly pointed out that PRR is valued at 30~c by a community of resource driven investors. Let's face it, the majority of us beer drinking blokes would be more comfortable making a fortune out of oil, hard materials and gold rather than the subtleties of immunotherapy. To emphasise, Australia is a material-driven economy. Once we're listed on the NASDAQ, we're exposed to a HUGE nation who know what they're talking about when it comes to this stuff. I allude to it on an everyday basis with my professors whilst at university - the funding for research at the US is several magnitudes higher than what our best institutions can dream about! When they look at a company like PRR, not only so far into it's development phase with a life-changing drug (a vaccine for cancer sufferers), but one that's been GIVEN THE MAJOR NOD in dubai, you think it's gonna stay at 33c? If only the sellers today could stop and think about what they are selling! We're not issuing extra stock for the NASDAQ - they're gonna be after our holdings. And they can have mine when they pry it out of my cold, dead hands. Buckle your seatbelts.

3. Worldwide penetration. I don't think it's appropriate to call PRR a 'speccy' anymore, given it's progress. Dubai will likely encourage other nations to take on Cvac. That means revenue for us shareholders. More importantly, it'll greatly encourage the FDA to give the big nod for use in the US if the drug is successful in major places in the world. For the sceptical folk (I was one before this announcement) - why would a world class medical facility in one of the most sophisticated places in the world give the 'go-ahead' to a penny stock from Australia (of all places) to commence treatment? We're onto something big here. The $2 party will be here when the Americans get their fill - and it's going to go well, well north after the drug hits worldwide.

Still thinking of selling for 32c?